Ferulic Acid Supplementation for Management of Depression in Epilepsy.

about

Ferulic Acid Supplementation for Management of Depression in Epilepsy.

Item

http://www.wikidata.org/entity/Q47858582

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ferulic Acid Supplementation for Management of Depression in Epilepsy.

@en

Ferulic Acid Supplementation for Management of Depression in Epilepsy.

@nl

type

Item

label

Ferulic Acid Supplementation for Management of Depression in Epilepsy.

@en

Ferulic Acid Supplementation for Management of Depression in Epilepsy.

@nl

prefLabel

Ferulic Acid Supplementation for Management of Depression in Epilepsy.

@en

Ferulic Acid Supplementation for Management of Depression in Epilepsy.

@nl

P1476

Ferulic Acid Supplementation for Management of Depression in Epilepsy.

@en

P2093

Rajesh Kumar Goel

http://www.w3.org/2001/XMLSchema#string

Tanveer Singh

http://www.w3.org/2001/XMLSchema#string

Taranjot Kaur

http://www.w3.org/2001/XMLSchema#string

P2860

Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression

Early Carcinogenesis Involves the Establishment of Immune Privilege via Intrinsic and Extrinsic Regulation of Indoleamine 2,3-dioxygenase-1: Translational Implications in Cancer Immunotherapy.

The neurobiology of depression and antidepressant action.

Kindling and status epilepticus models of epilepsy: rewiring the brain.

Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression

Synergistic antidepressant-like effect of ferulic acid in combination with piperine: involvement of monoaminergic system.

Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine.

The neurobehavioural comorbidities of epilepsy: can a natural history be developed?

Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

P2888

s11064-017-2325-6

P304

2940-2948

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11064-017-2325-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28608235

http://www.w3.org/2001/XMLSchema#string